Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease.
暂无分享,去创建一个
A. J. Slater | Rachel L. Taylor | P. Matthews | M. Owen | K. King | A. Roses | M. Ehm | P. S. St George-Hyslop | R. Keren | H. Feldman | S. Gauthier | M. Barnes | S. Lovestone | M. Borrie | P. Hollingworth | Julie Williams | A. Kertesz | P. S. St. Jean | A. Saunders | Hao Li | S. Wetten | Li Li | R. Upmanyu | L. Surh | D. Hosford | J. Briley | Natalie Coletta | Richard Delisle | Daniella Dhalla | L. Fornazzari | Neil Goodgame | D. Guzman | Sandra Hammond | G. Hsiung | Joan Johnson | Devon Kelly | I. Loy-English | M. Plumpton | W. Pryse-Phillips | R. Prinjha | J. Richardson | A. Slater | S. Stinnett | J. Swartz | J. Wherrett | D. Yarnall | R. Gibson | M. Irizarry | L. Middleton | P. S. St Jean | J. D. Briley | R. Taylor | Inge Loy-English | J. Richardson
[1] B. Reisberg,et al. The Global Deterioration Scale for assessment of primary degenerative dementia. , 1982, The American journal of psychiatry.
[2] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[3] Gerda G. Fillenbaum,et al. Multidimensional Functional Assessment of Older Adults: The Duke Older Americans Resources and Services Procedures , 1988 .
[4] Isabelle Rouleau,et al. Quantitative and qualitative analyses of clock drawings in Alzheimer's and Huntington's disease , 1992, Brain and Cognition.
[5] S. Gauthier,et al. Apolipoprotein E polymorphism and Alzheimer's disease , 1993, The Lancet.
[6] M A Pericak-Vance,et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. , 1993, Neurology.
[7] J. Rabe-Jabłońska,et al. [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders]. , 1993, Psychiatria polska.
[8] M. Folstein,et al. Population-based norms for the Mini-Mental State Examination by age and educational level. , 1993, JAMA.
[9] Canadian study of health and aging: study methods and prevalence of dementia. , 1994, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[10] F. Fazekas,et al. The Mattis Dementia Rating Scale , 1994, Neurology.
[11] K. Roeder,et al. Genomic Control for Association Studies , 1999, Biometrics.
[12] R. Kladney,et al. GP73, a novel Golgi-localized protein upregulated by viral infection , 2000, Gene.
[13] T. Nagase,et al. Prediction of the coding sequences of unidentified human genes. XXII. The complete sequences of 50 new cDNA clones which code for large proteins. , 2001, DNA research : an international journal for rapid publication of reports on genes and genomes.
[14] M. Albert,et al. Results of a high-resolution genome screen of 437 Alzheimer's disease families. , 2003, Human molecular genetics.
[15] Yasunori Hayashi,et al. The Importance of Dendritic Mitochondria in the Morphogenesis and Plasticity of Spines and Synapses , 2004, Cell.
[16] Lefkos Middleton,et al. Disease-specific target selection: a critical first step down the right road. , 2005, Drug discovery today.
[17] Chad Haynes,et al. PAWE-3D: visualizing power for association with error in case-control genetic studies of complex traits , 2005, Bioinform..
[18] R. Mahley,et al. Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[19] M. Owen,et al. Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer's disease , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[20] D. Galati,et al. Accumulation of Amyloid Precursor Protein in the Mitochondrial Import Channels of Human Alzheimer’s Disease Brain Is Associated with Mitochondrial Dysfunction , 2006, The Journal of Neuroscience.
[21] A D Roses,et al. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease , 2006, The Pharmacogenomics Journal.
[22] Michael R. Barnes,et al. Navigating the HapMap , 2006, Briefings Bioinform..
[23] G. Abecasis,et al. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies , 2006, Nature Genetics.
[24] Terence P. Speed,et al. Genome analysis A genotype calling algorithm for affymetrix SNP arrays , 2005 .
[25] Winnie S. Liang,et al. GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. , 2007, Neuron.
[26] Yaakov Stern,et al. The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort. , 2007, Archives of neurology.
[27] A D Roses,et al. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease) , 2007, The Pharmacogenomics Journal.
[28] Peter Kraft,et al. Drinking from the fire hose--statistical issues in genomewide association studies. , 2007, The New England journal of medicine.
[29] D. Blacker,et al. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database , 2007, Nature Genetics.
[30] Allan R. Jones,et al. Genome-wide atlas of gene expression in the adult mouse brain , 2007, Nature.
[31] J. Hirschhorn,et al. Genetic model testing and statistical power in population‐based association studies of quantitative traits , 2007, Genetic epidemiology.
[32] Winnie S. Liang,et al. GAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 Carriers , 2007, Neuron.
[33] Simon C. Potter,et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.
[34] P. Donnelly,et al. Replicating genotype–phenotype associations , 2007, Nature.
[35] K. Lunetta,et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease , 2007, Nature Genetics.
[36] M. Gill,et al. Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants. , 2007, Human molecular genetics.
[37] Rebecca F. Halperin,et al. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. , 2007, The Journal of clinical psychiatry.